eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Amgen, Inc. - Testimony

Amgen, Inc. - Testimony

Document ID: FDA-2012-N-0408-0008
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: June 08 2012, at 12:00 AM Eastern Daylight Time
Date Posted: June 15 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: May 3 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: July 7 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 8103d766
View Document:  View as format xml

View Comment

Attached is Amgen, Inc's presentation given at the Open Public Session during this FDA Workshop.

Attachments:

Amgen FDA REMS Public Workshop Presentation

Title:
Amgen FDA REMS Public Workshop Presentation

View Attachment: View as format pdf

Related Comments

    View All
Total: 23
Jancy Walter - Comment
Public Submission    Posted: 06/04/2012     ID: FDA-2012-N-0408-0002

Jul 07,2012 11:59 PM ET
Amgen, Inc. - Testimony
Public Submission    Posted: 06/15/2012     ID: FDA-2012-N-0408-0008

Jul 07,2012 11:59 PM ET
Richard Brian Attig - Comment
Public Submission    Posted: 06/15/2012     ID: FDA-2012-N-0408-0010

Jul 07,2012 11:59 PM ET
Farmacia Electronica, Inc. - Comment
Public Submission    Posted: 07/03/2012     ID: FDA-2012-N-0408-0011

Jul 07,2012 11:59 PM ET
AstraZeneca - Comment
Public Submission    Posted: 07/03/2012     ID: FDA-2012-N-0408-0012

Jul 07,2012 11:59 PM ET